Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...Read more
Guangzhou records a whopping growth of over 50%
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...Read more
What are the key mergers & acquisitions of Q1 2013?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...Read more
Australia is 3rd largest in terms of total company revenues
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar ...Read more
What were the top 20 M&A deals in pharma and biotech sector in 2012?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...Read more
India ranks 2nd in terms of total company revenues
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
India emerged as the second largest country in terms of the total revenue generated by companies during the calendar yea...Read more